Search Within

Sandra Pierina D'Angelo

Formats
  1. Meeting Abstract (137)
  2. Journal Article (107)
  3. Review (4)
  4. Research Letter (3)
  5. Book Section (1)
  6. Book Whole (1)
  7. Editorial (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (256)
  2. Hematologic Malignancies, Division of (256)
  3. Sarcoma Service (256)
  4. Solid Tumor Oncology Division (256)
  5. GSK Faculty (104)
  6. Tow Center for Developmental Oncology (TCDO) (91)

More Groups

People
  1. William Tap (107)
  2. Mark Dickson (86)
  3. Mrinal Gounder (75)
  4. Mary Keohan (73)
  5. Ping Chi (61)
  6. Cristina Antonescu (55)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (32)
  5. 2021 (16)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (102)
  2. Journal for ImmunoTherapy of Cancer (24)
  3. Annals of Oncology (16)
  4. Clinical Cancer Research (12)
  5. JAMA Oncology (5)
  6. Journal of Thoracic Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (104)
  2. Biomed Central Ltd (26)
  3. Oxford University Press (20)
  4. American Association for Cancer Research (19)
  5. Elsevier Inc. (16)
  6. Springer (9)

More Publishers

Results (256)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Avelumab immunotherapy: Management of adverse events associated with new treatment for Merkel cell carcinoma
    Journal Article

    Ugolini, H.; Bryan, J.; Hennessy, M.; Kaufman, H. L.; D'Angelo, S. P.
    Clinical Journal of Oncology Nursing (2019)

    Fulltext@MSK | Save
  • Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial
    Journal Article

    Chung, D. J.; Carvajal, R. D.; Postow, M. A.; Sharma, S.; Pronschinske, K. B.; Shyer, J. A.; Singh-Kandah, S.; Dickson, M. A.; D'Angelo, S. P.; Wolchok, J. D.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Projecting long term survival for avelumab in refractory Merkel cell carcinoma
    Meeting Abstract

    Phatak, H.; Proskorovsky, I.; Lanitis, T.; Ambavane, A.; Hunger, M.; D'Angelo, S. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy
    Meeting Abstract

    Nghiem, P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab
    Meeting Abstract

    Bullement, A.; D'Angelo, S. P.; Amin, A.; Stapelkamp, C.; Willis, A.; Lilley, C.; Hatswell, A.; Bharmal, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors in sarcoma
    Book Section

    D'Angelo, S. P.; Kelly, C. M.
    In D'Angelo, S. P.; Pollack, S. M. (Eds.) Immunotherapy of Sarcoma (2018)

    Fulltext@MSK | Save
  • REVEAL: A phase I/II, open-label, multicenter, dose escalation and dose expansion study of NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] with or without nivolumab (nivo) in patients (pts) with locally advanced or metastatic solid tumor malignancies
    Meeting Abstract

    Diab, A.; Marcondes, M.; Tagliaferri, M. A.; Hoch, U.; Zhang, J.; Rubas, W.; Kivimae, S.; Zalevsky, J.; Conley, A. P.; Borazanci, E.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Responder analysis based on patient-reported outcomes (PROs) and clinical endpoints (CEPs) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab
    Meeting Abstract

    D'Angelo, S. P.; Fofana, F.; Schlichting, M.; Henry-Szatkowski, M.; Hennessy, M.; Bharmal, M.
    Annals of Oncology (2018)

    Fulltext@MSK | Save